Gallus Biopharmaceuticals – Contract Manufacturer of Mammalian Cell Biologics

Gallus Biopharma is a mammalian cell culture contract development and manufacturing organization (CMO) that offers a unique level of flexibility and strategic appeal to companies seeking to develop and manufacture biologics. As a pure-play CMO, we deliver a high level of quality and reliability to our clinical and commercial clients. With the acquisition of Laureate BioPharmaceuticals in 2013, we strengthened our capabilities with increased service offerings and capacity in our combined locations of St. Louis, Missouri and Princeton, New Jersey.

In addition to a stellar commercial manufacturing history Gallus Biopharma offers clinical and commercial fill-finish, a pilot facility and expanded analytics including mass spectrophotometry. Our expanded team of 370 dedicated professionals has a combined experience of nearly six decades of biologics manufacturing experience, with an exceptional focus on quality evidenced in a high frequency of tech transfers and a long-term exemplary regulatory record. We provide value for your molecule in our uniquely flexible services and business models, including utilizing advanced technologies to improve upstream and downstream processes, reduce project timelines and optimize yields.

Gallus has significantly expanded our process development laboratories and clinical services suites using single-use technologies, stainless steel and flexible stainless steel and have built our talent pool with industry-recognized expertise in cell culture, purification, analytical development and project management. Combined, Gallus’ team and facilities provide the exceptional service you seek for developing and manufacturing the biologic therapies of the future.

The Gallus team is ready to demonstrate our flexibility and how far we’ll go to work for you.